vs
Fair Isaac（FICO）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
West Pharmaceutical Services的季度营收约是Fair Isaac的1.6倍（$805.0M vs $512.0M），Fair Isaac净利率更高（30.9% vs 16.4%，领先14.5%），Fair Isaac同比增速更快（16.4% vs 7.5%），West Pharmaceutical Services自由现金流更多（$175.0M vs $173.9M），过去两年Fair Isaac的营收复合增速更高（8.6% vs 7.6%）
FICO（原Fair, Isaac and Company）是美国知名数据分析企业，1956年由比尔·费尔与厄尔·艾萨克创立，总部位于蒙大拿州博兹曼市，核心业务为信用评分服务，其推出的FICO信用分是评估消费者信贷风险的重要指标，目前已被美国消费信贷行业广泛采用。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
FICO vs WST — 直观对比
营收规模更大
WST
是对方的1.6倍
$512.0M
营收增速更快
FICO
高出8.9%
7.5%
净利率更高
FICO
高出14.5%
16.4%
自由现金流更多
WST
多$1.1M
$173.9M
两年增速更快
FICO
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $512.0M | $805.0M |
| 净利润 | $158.4M | $132.1M |
| 毛利率 | 83.0% | 37.8% |
| 营业利润率 | 45.7% | 19.5% |
| 净利率 | 30.9% | 16.4% |
| 营收同比 | 16.4% | 7.5% |
| 净利润同比 | 3.8% | 1.5% |
| 每股收益（稀释后） | $6.61 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FICOWST
| Q4 25 | $512.0M | $805.0M | ||
| Q3 25 | $515.8M | $804.6M | ||
| Q2 25 | $536.4M | $766.5M | ||
| Q1 25 | $498.7M | $698.0M | ||
| Q4 24 | $440.0M | $748.8M | ||
| Q3 24 | $453.8M | $746.9M | ||
| Q2 24 | $447.8M | $702.1M | ||
| Q1 24 | $433.8M | $695.4M |
净利润FICOWST
| Q4 25 | $158.4M | $132.1M | ||
| Q3 25 | $155.0M | $140.0M | ||
| Q2 25 | $181.8M | $131.8M | ||
| Q1 25 | $162.6M | $89.8M | ||
| Q4 24 | $152.5M | $130.1M | ||
| Q3 24 | $135.7M | $136.0M | ||
| Q2 24 | $126.3M | $111.3M | ||
| Q1 24 | $129.8M | $115.3M |
毛利率FICOWST
| Q4 25 | 83.0% | 37.8% | ||
| Q3 25 | 82.3% | 36.6% | ||
| Q2 25 | 83.7% | 35.7% | ||
| Q1 25 | 82.4% | 33.2% | ||
| Q4 24 | 80.1% | 36.5% | ||
| Q3 24 | 80.3% | 35.4% | ||
| Q2 24 | 80.3% | 32.8% | ||
| Q1 24 | 80.0% | 33.1% |
营业利润率FICOWST
| Q4 25 | 45.7% | 19.5% | ||
| Q3 25 | 46.0% | 20.8% | ||
| Q2 25 | 48.9% | 20.1% | ||
| Q1 25 | 49.3% | 15.3% | ||
| Q4 24 | 40.8% | 21.3% | ||
| Q3 24 | 43.4% | 21.6% | ||
| Q2 24 | 42.5% | 18.0% | ||
| Q1 24 | 44.9% | 17.7% |
净利率FICOWST
| Q4 25 | 30.9% | 16.4% | ||
| Q3 25 | 30.1% | 17.4% | ||
| Q2 25 | 33.9% | 17.2% | ||
| Q1 25 | 32.6% | 12.9% | ||
| Q4 24 | 34.7% | 17.4% | ||
| Q3 24 | 29.9% | 18.2% | ||
| Q2 24 | 28.2% | 15.9% | ||
| Q1 24 | 29.9% | 16.6% |
每股收益（稀释后）FICOWST
| Q4 25 | $6.61 | $1.82 | ||
| Q3 25 | $6.41 | $1.92 | ||
| Q2 25 | $7.40 | $1.82 | ||
| Q1 25 | $6.59 | $1.23 | ||
| Q4 24 | $6.14 | $1.78 | ||
| Q3 24 | $5.44 | $1.85 | ||
| Q2 24 | $5.05 | $1.51 | ||
| Q1 24 | $5.16 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $162.0M | $791.3M |
| 总债务越低越好 | $3.2B | $202.8M |
| 股东权益账面价值 | $-1.8B | $3.2B |
| 总资产 | $1.9B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资FICOWST
| Q4 25 | $162.0M | $791.3M | ||
| Q3 25 | $134.1M | $628.5M | ||
| Q2 25 | $189.0M | $509.7M | ||
| Q1 25 | $146.6M | $404.2M | ||
| Q4 24 | $184.3M | $484.6M | ||
| Q3 24 | $150.7M | $490.9M | ||
| Q2 24 | $156.0M | $446.2M | ||
| Q1 24 | $135.7M | $601.8M |
总债务FICOWST
| Q4 25 | $3.2B | $202.8M | ||
| Q3 25 | $3.1B | $202.7M | ||
| Q2 25 | $2.8B | $202.6M | ||
| Q1 25 | $2.5B | $202.6M | ||
| Q4 24 | $2.4B | $202.6M | ||
| Q3 24 | $2.2B | $202.6M | ||
| Q2 24 | $2.1B | $205.8M | ||
| Q1 24 | $2.0B | $206.2M |
股东权益FICOWST
| Q4 25 | $-1.8B | $3.2B | ||
| Q3 25 | $-1.7B | $3.1B | ||
| Q2 25 | $-1.4B | $2.9B | ||
| Q1 25 | $-1.1B | $2.7B | ||
| Q4 24 | $-1.1B | $2.7B | ||
| Q3 24 | $-962.7M | $2.8B | ||
| Q2 24 | $-829.3M | $2.6B | ||
| Q1 24 | $-735.7M | $2.7B |
总资产FICOWST
| Q4 25 | $1.9B | $4.3B | ||
| Q3 25 | $1.9B | $4.1B | ||
| Q2 25 | $1.9B | $4.0B | ||
| Q1 25 | $1.8B | $3.6B | ||
| Q4 24 | $1.7B | $3.6B | ||
| Q3 24 | $1.7B | $3.7B | ||
| Q2 24 | $1.7B | $3.5B | ||
| Q1 24 | $1.7B | $3.6B |
负债/权益比FICOWST
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $174.1M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $173.9M | $175.0M |
| 自由现金流率自由现金流/营收 | 34.0% | 21.7% |
| 资本支出强度资本支出/营收 | 0.0% | 9.5% |
| 现金转化率经营现金流/净利润 | 1.10× | 1.90× |
| 过去12个月自由现金流最近4个季度 | $750.6M | $468.9M |
8季度趋势，按日历期对齐
经营现金流FICOWST
| Q4 25 | $174.1M | $251.1M | ||
| Q3 25 | $223.7M | $197.2M | ||
| Q2 25 | $286.2M | $177.1M | ||
| Q1 25 | $74.9M | $129.4M | ||
| Q4 24 | $194.0M | $190.1M | ||
| Q3 24 | $226.5M | $180.1M | ||
| Q2 24 | $213.3M | $165.0M | ||
| Q1 24 | $71.0M | $118.2M |
自由现金流FICOWST
| Q4 25 | $173.9M | $175.0M | ||
| Q3 25 | $219.5M | $133.9M | ||
| Q2 25 | $284.4M | $101.9M | ||
| Q1 25 | $72.8M | $58.1M | ||
| Q4 24 | $193.2M | $85.2M | ||
| Q3 24 | $224.7M | $98.8M | ||
| Q2 24 | $211.6M | $64.8M | ||
| Q1 24 | $67.0M | $27.6M |
自由现金流率FICOWST
| Q4 25 | 34.0% | 21.7% | ||
| Q3 25 | 42.6% | 16.6% | ||
| Q2 25 | 53.0% | 13.3% | ||
| Q1 25 | 14.6% | 8.3% | ||
| Q4 24 | 43.9% | 11.4% | ||
| Q3 24 | 49.5% | 13.2% | ||
| Q2 24 | 47.2% | 9.2% | ||
| Q1 24 | 15.4% | 4.0% |
资本支出强度FICOWST
| Q4 25 | 0.0% | 9.5% | ||
| Q3 25 | 0.8% | 7.9% | ||
| Q2 25 | 0.3% | 9.8% | ||
| Q1 25 | 0.4% | 10.2% | ||
| Q4 24 | 0.2% | 14.0% | ||
| Q3 24 | 0.4% | 10.9% | ||
| Q2 24 | 0.4% | 14.3% | ||
| Q1 24 | 0.9% | 13.0% |
现金转化率FICOWST
| Q4 25 | 1.10× | 1.90× | ||
| Q3 25 | 1.44× | 1.41× | ||
| Q2 25 | 1.57× | 1.34× | ||
| Q1 25 | 0.46× | 1.44× | ||
| Q4 24 | 1.27× | 1.46× | ||
| Q3 24 | 1.67× | 1.32× | ||
| Q2 24 | 1.69× | 1.48× | ||
| Q1 24 | 0.55× | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FICO
| Business To Business Scores | $248.6M | 49% |
| Saa S Products | $115.7M | 23% |
| Platform Software | $73.9M | 14% |
| Business To Consumer Scores | $55.9M | 11% |
| Technology Service | $19.2M | 4% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
